id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_o2zqy6aj6bgprixtqg7ee73eeu	Amish Acharya	Use of Tumor Markers in Gastrointestinal Cancers: Surgeon Perceptions and Cost-Benefit Trade-Off Analysis	2016.0	9	.pdf	application/pdf	6481	2153	79	Use of Tumor Markers in Gastrointestinal Cancers: Surgeon heterogeneity and ability to predict recurrence and metastases for carcinoembryonic antigen (CEA), cancer antigen studies and survey were combined in a cost-benefit tradeoff analysis to assess which tumor markers are of most use cost-benefit trade-off of three common tumor markers in articles assessed colorectal tumor markers (42 on diagnostic ability, 28 on prediction of recurrence, and 32 on the most commonly utilized tumor marker in colorectal cancer (Fig. 2a), with surveillance for 3 Cost-benefit trade-off for use of the tumor markers in Use of Tumor Markers in Gastrointestinal Cancers 1173 Use of Tumor Markers in Gastrointestinal Cancers 1173 Use of Tumor Markers in Gastrointestinal Cancers 1173 Use of Tumor Markers in Gastrointestinal Cancers 1173 Use of Tumor Markers in Gastrointestinal Cancers 1173 Use of Tumor Markers in Gastrointestinal Cancers: Surgeon Perceptions and Cost-Benefit Trade-Off Analysis	./cache/work_o2zqy6aj6bgprixtqg7ee73eeu.pdf	./txt/work_o2zqy6aj6bgprixtqg7ee73eeu.txt